ddavp desmopressin acetate tablet
sanofi-aventis u.s. llc - desmopressin acetate (unii: xb13hyu18u) (desmopressin - unii:enr1llb0fp) - desmopressin 0.1 mg
nocdurna- desmopressin acetate tablet
ferring pharmaceuticals inc. - desmopressin acetate (unii: xb13hyu18u) (desmopressin - unii:enr1llb0fp) - nocdurna is indicated for the treatment of nocturia due to nocturnal polyuria in adults who awaken at least 2 times per night to void. in the nocdurna clinical trials nocturnal polyuria was defined as night-time urine production exceeding one-third of the 24-hour urine production. before starting nocdurna: - evaluate the patient for possible causes for the nocturia, including excessive fluid intake prior to bedtime, and address other treatable causes of nocturia. - confirm the diagnosis of nocturnal polyuria with a 24-hour urine collection, if one has not been obtained previously. nocdurna is contraindicated in patients with the following conditions due to an increased risk of hyponatremia: - hyponatremia or a history of hyponatremia [see warnings and precautions (5.1)] . - polydipsia - concomitant use with loop diuretics [see warnings and precautions (5.1)] - concomitant use with systemic or inhaled glucocorticoids [see warnings and precautions (5.2), drug interactions (7.1)] - renal impairment with estimate
nocdurna- desmopressin acetate tablet
antares pharma, inc. - desmopressin acetate (unii: xb13hyu18u) (desmopressin - unii:enr1llb0fp) - nocdurna is indicated for the treatment of nocturia due to nocturnal polyuria in adults who awaken at least 2 times per night to void. in the nocdurna clinical trials nocturnal polyuria was defined as night-time urine production exceeding one-third of the 24-hour urine production. before starting nocdurna: - evaluate the patient for possible causes for the nocturia, including excessive fluid intake prior to bedtime, and address other treatable causes of nocturia. - confirm the diagnosis of nocturnal polyuria with a 24-hour urine collection, if one has not been obtained previously. nocdurna is contraindicated in patients with the following conditions due to an increased risk of hyponatremia: - hyponatremia or a history of hyponatremia [see warnings and precautions (5.1)] . - polydipsia - concomitant use with loop diuretics [see warnings and precautions (5.1)] - concomitant use with systemic or inhaled glucocorticoids [see warnings and precautions (5.2), drug interactions (7.1)] - renal impairment with estimate
minirin desmopressin acetate 0.1mg/ml nasal drops bottle
ferring pharmaceuticals pty ltd - desmopressin acetate -
minirin desmopressin acetate 200 microgram tablet bottle
ferring pharmaceuticals pty ltd - desmopressin acetate, quantity: 0.2 mg (equivalent: desmopressin, qty 178 microgram) - tablet, uncoated - excipient ingredients: magnesium stearate; lactose monohydrate; povidone; potato starch - minirin tablets are indicated for the treatment of: cranial diabetes insipidus; primary nocturnal enuresis, in patients from 6 years of age with normal ability to concentrate urine, who are refractory to an enuresis alarm, or in whom an enuresis alarm is contraindicated or inappropriate.
desmopressin acetate trihydrate powder
ax pharmaceutical corp - desmopressin acetate (unii: xb13hyu18u) (desmopressin acetate - unii:xb13hyu18u) -
desmopressin acetate trihydrate powder
zhejiang peptites biotech co.,ltd. - desmopressin acetate (unii: xb13hyu18u) (desmopressin - unii:enr1llb0fp) -
ddavp desmopressin 100 micrograms/ml nasal drops, solution
ferring ireland ltd - desmopressin acetate - nasal drops, solution - 100 microgram(s)/millilitre - vasopressin and analogues; desmopressin
desmopressin 10micrograms/dose nasal spray
accord-uk ltd - desmopressin acetate - spray - 10microgram/1dose
desmopressin-ph&t
aft pharmaceuticals ltd - desmopressin acetate trihydrate 0.1mg equivalent to desmopressin 0.0890 mg; - tablet - 100 mcg - active: desmopressin acetate trihydrate 0.1mg equivalent to desmopressin 0.0890 mg excipient: lactose monohydrate magnesium stearate maize starch povidone